InsiderGauge
Checking updates…
Dashboard

ACADACADIA PHARMACEUTICALS INC insider trades

In the last 90 days, 1 insider sold $69.3K of Acadia Pharmaceuticals Inc (ACAD) on the open market and none bought.

Market cap
$3.53B
as of 2026-10-30
Latest close
$20.76
as of 2026-10-29
Sector
Healthcare
as of 2026-10-31
Industry
Biotechnology
as of 2026-10-31

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2023-10-06

Showing the latest 100 of 332 transactions. Search the ledger for ACAD

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROct 30Oct 30S3,321$20.88Sale −$69,34271,322NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICEROct 15Oct 30A6,815$0.00$074,643NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 6Aug 7M14,292$17.84$254,96982,120YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 6Aug 7S5,000$29.00Sale −$145,00077,120YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 6Aug 7S9,292$29.34Sale −$272,62767,828YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 6Aug 7M · derivative14,292$17.84$254,96960,423YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 5Aug 7M5,849$17.84$104,34673,677YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 5Aug 7S5,849$29.00Sale −$169,62167,828YesForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERAug 5Aug 7M · derivative5,849$17.84$104,34674,715YesForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevJul 30Jul 31S16,508$26.13Sale −$431,35419,044NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevJul 30Jul 31S50$26.17Sale −$1,30918,994NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevJul 29Jul 31M32,272not reportednot reported35,552NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevJul 29Jul 31M · derivative32,272$0.00$032,272NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERJun 26Jun 29S11,421$26.08Sale −$297,86013,088YesForm 4
Baker Brothers Life Sciences LPMay 29Jun 2A18,622$0.00$03,677,357NoForm 4
Baker Brothers Life Sciences LPMay 29Jun 2A18,622$0.00$039,384,587NoForm 4
Baker Brothers Life Sciences LPMay 29Jun 2A · derivative32,008$21.66$693,29332,008NoForm 4
Baker Brothers Life Sciences LPMay 29Jun 2A · derivative32,008$21.66$693,29332,008NoForm 4
Harrigan EdmundMay 29Jun 1M8,107not reportednot reported43,148NoForm 4
Harrigan EdmundMay 29Jun 1M · derivative8,107$0.00$0not reportedNoForm 4
Harrigan EdmundMay 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Harrigan EdmundMay 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Brege LauraMay 29Jun 1M8,107not reportednot reported23,202NoForm 4
Brege LauraMay 29Jun 1M · derivative8,107$0.00$0not reportedNoForm 4
Brege LauraMay 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Brege LauraMay 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Daly James MMay 29Jun 1M8,107not reportednot reported12,148NoForm 4
Daly James MMay 29Jun 1M · derivative8,107$0.00$0not reportedNoForm 4
Daly James MMay 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Daly James MMay 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Poole JonathanMay 29Jun 1M2,010not reportednot reported2,010NoForm 4
Poole JonathanMay 29Jun 1M · derivative2,010$0.00$0not reportedNoForm 4
Poole JonathanMay 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Poole JonathanMay 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Garofalo Elizabeth A.May 29Jun 1M8,107not reportednot reported33,489NoForm 4
Garofalo Elizabeth A.May 29Jun 1M · derivative8,107$0.00$0not reportedNoForm 4
Garofalo Elizabeth A.May 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Garofalo Elizabeth A.May 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Ndu AdoraMay 29Jun 1M8,107not reportednot reported32,908NoForm 4
Ndu AdoraMay 29Jun 1M · derivative8,107$0.00$0not reportedNoForm 4
Ndu AdoraMay 29Jun 1A · derivative16,004$21.66$346,64716,004NoForm 4
Ndu AdoraMay 29Jun 1A · derivative9,311$0.00$09,311NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 26May 27S5,401$21.18Sale −$114,39324,509NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 4May 5S1,332$21.79Sale −$29,02429,129NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 4May 5S3,506$21.79Sale −$76,39666,145NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 1May 5M2,596not reportednot reported30,461NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMay 1May 5M · derivative2,596$0.00$02,596NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 1May 5M6,815not reportednot reported69,651NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMay 1May 5M · derivative6,815$0.00$06,815NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 7Apr 7S1,030$22.20Sale −$22,86627,865NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 7Apr 7S2,709$22.20Sale −$60,14062,836NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 5Apr 7M2,010not reportednot reported28,895NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERApr 5Apr 7M · derivative2,010$0.00$0not reportedNoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 5Apr 7M5,276not reportednot reported65,545NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERApr 5Apr 7M · derivative5,276$0.00$0not reportedNoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 26Mar 26S1,097$21.65Sale −$23,75026,897NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 26Mar 26S12$21.73Sale −$26126,885NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 26Mar 26S3,171$21.65Sale −$68,65260,306NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 26Mar 26S37$21.72Sale −$80460,269NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECMar 25Mar 26S3,844$21.47Sale −$82,53111,280NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 25Mar 26S833$21.47Sale −$17,88525,852NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 25Mar 26M2,142not reportednot reported27,994NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 25Mar 26M · derivative2,142$0.00$04,284NoForm 4
Owen Adams CatherineChief Executive OfficerMar 25Mar 26S11,641$21.47Sale −$249,93214,803NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevMar 25Mar 26S3,435$21.47Sale −$73,7493,280NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 25Mar 26S4,177$21.47Sale −$89,68057,299NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 25Mar 26M6,178not reportednot reported63,477NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 25Mar 26M · derivative6,178$0.00$012,358NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECMar 24Mar 26M7,515$0.00$015,124NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECMar 24Mar 26M · derivative7,515$0.00$022,547NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 24Mar 26M1,627not reportednot reported26,685NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 24Mar 26M · derivative1,627$0.00$04,883NoForm 4
Owen Adams CatherineChief Executive OfficerMar 24Mar 26M23,509$0.00$026,444NoForm 4
Owen Adams CatherineChief Executive OfficerMar 24Mar 26M · derivative23,509$0.00$070,530NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevMar 24Mar 26M6,715not reportednot reported6,715NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevMar 24Mar 26M · derivative6,715$0.00$020,146NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 24Mar 26M8,138not reportednot reported61,476NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 24Mar 26M · derivative8,138$0.00$024,414NoForm 4
Poole JonathanMar 3Mar 20A · derivative7,482$22.50$168,3457,482NoForm 4
Poole JonathanMar 3Mar 20A · derivative3,565$22.50$80,2133,565NoForm 4
Poole JonathanMar 3Mar 20A · derivative4,218$0.00$04,218NoForm 4
Poole JonathanMar 3Mar 20A · derivative2,010$0.00$02,010NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECMar 6Mar 10A · derivative90,691$22.16$2,009,71390,691NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECMar 6Mar 10A · derivative26,382$0.00$026,382NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 6Mar 10A · derivative21,766$22.16$482,33521,766NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERMar 6Mar 10A · derivative6,332$0.00$06,332NoForm 4
Owen Adams CatherineChief Executive OfficerMar 6Mar 10A · derivative263,005$22.16$5,828,191263,005NoForm 4
Owen Adams CatherineChief Executive OfficerMar 6Mar 10A · derivative76,509$0.00$076,509NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevMar 6Mar 10A · derivative101,574$22.16$2,250,880101,574NoForm 4
Thompson Elizabeth H.Z.EVP, Head of Research & DevMar 6Mar 10A · derivative29,548$0.00$029,548NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 6Mar 10A · derivative90,691$22.16$2,009,71390,691NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERMar 6Mar 10A · derivative26,382$0.00$026,382NoForm 4
Garner ThomasEVP, Chief Commercial OfficerMar 6Mar 10A · derivative97,947$22.16$2,170,50697,947NoForm 4
Garner ThomasEVP, Chief Commercial OfficerMar 6Mar 10A · derivative28,493$0.00$028,493NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECFeb 9Feb 10S6,950$23.38Sale −$162,4917,609NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECFeb 6Feb 10M12,944$0.00$014,559NoForm 4
Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SECFeb 6Feb 10M · derivative12,944$0.00$012,945NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERNov 18, 2025Nov 19, 2025S4,084$23.69Sale −$96,75025,058NoForm 4
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICERNov 18, 2025Nov 19, 2025S10,262$23.69Sale −$243,10753,338NoForm 4
Kihara JamesPRINCIPAL ACCOUNTING OFFICERNov 17, 2025Nov 19, 2025M3,966not reportednot reported25,176NoForm 4